Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nivolumab

Pseudoprogression in the form of pleural and pericardial effusions: case report

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Nakamura R, et al. Non-small cell lung cancer with second pseudoprogression after an increase in the nivolumab dose: A case report. Haigan / Japanese Journal of Lung Cancer 59: 1167-1170, No. 7, Dec 2019. Available from: URL: http://doi.org/10.2482/haigan.59.1167 [Japanese; summarised from an English abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Nivolumab. Reactions Weekly 1790, 174 (2020). https://doi.org/10.1007/s40278-020-74792-3

    Download citation